Adeline Wang

Adeline Wang currently serves as the Director of Breast Cancer in Field Medical at Pfizer, a position held since June 2020. Prior to this role, Adeline worked at Sanofi Genzyme as a Senior Medical Science Liaison focusing on Rare Blood Diseases and Global Medical Affairs, contributing to the launch preparation for Caplacizumab. Adeline's experience also includes serving as a Senior Medical Science Liaison at Mallinckrodt Pharmaceuticals, where responsibilities involved critical care activities, and at Boehringer Ingelheim in various roles, including Health Science Executive and Principal Scientist, with a focus on respiratory therapeutic areas. Adeline's academic credentials include a Postdoctoral training in Vascular Biology from the University of Washington, a PhD in Physiology from the University of Manitoba, a Master of Science in Cardiovascular Pathophysiology from Beijing Medical University, and an MD from China Medical University.